Medii and Japanese Society of Child Neurology Jointly Build 'Physician Collaboration System' for Safety Management of Regenerative Medicine for Duchenne Muscular Dystrophy
NQ Score
48/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Medii and the Japanese Society of Child Neurology have established a digital system to support the safety management and proper use of 'Elevidys,' the first regenerative medicine for Duchenne Muscular Dystrophy in Japan. Utilizing 'Medii E-Consult,' the system connects treating physicians with an expert panel for rapid clinical decision support.